Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEBPA Antikörper (pSer21)

CEBPA Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN6256190
  • Target Alle CEBPA Antikörper anzeigen
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Bindungsspezifität
    • 18
    • 14
    • 11
    • 9
    • 9
    • 8
    • 7
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer21
    Reaktivität
    • 98
    • 77
    • 68
    • 8
    • 5
    • 5
    • 5
    • 5
    • 3
    • 3
    • 3
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 101
    • 4
    • 1
    • 1
    Kaninchen
    Klonalität
    • 96
    • 11
    Polyklonal
    Konjugat
    • 44
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CEBPA Antikörper ist unkonjugiert
    Applikation
    • 65
    • 40
    • 19
    • 16
    • 15
    • 15
    • 10
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
    Spezifität
    Phospho-C/EBP alpha (Ser21) Antibody detects endogenous levels of C/EBP alpha only when phosphorylated at Serine 21.
    Homologie
    Pig,Bovine
    Aufreinigung
    The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho- and non-phospho-peptide affinity columns.
    Immunogen
    A synthesized peptide derived from human C/EBP- alpha around the phosphorylation site of Ser21.
    Isotyp
    IgG
    Top Product
    Discover our top product CEBPA Primärantikörper
  • Applikationshinweise
    WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20 °C. Stable for 12 months from date of receipt.
    Haltbarkeit
    12 months
  • Target
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Andere Bezeichnung
    CEBPA (CEBPA Produkte)
    Synonyme
    C/EBP-alpha antikoerper, CEBP antikoerper, C/ebpalpha antikoerper, CBF-A antikoerper, Cebp antikoerper, DBPCEP antikoerper, c/ebpa antikoerper, cb1062 antikoerper, wu:fj20f03 antikoerper, C/EBP antikoerper, C/EBPalpha antikoerper, xC/EBP antikoerper, cC/EBP antikoerper, C/EBP alpha antikoerper, CCAAT/enhancer binding protein alpha antikoerper, CCAAT/enhancer binding protein (C/EBP), alpha antikoerper, CCAAT/enhancer binding protein alpha L homeolog antikoerper, CEBPA antikoerper, Cebpa antikoerper, cebpa antikoerper, cebpa.L antikoerper
    Hintergrund

    Description: Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5'-T[TG]NNGNAA[TG]-3' acting as an activator on distinct target genes (PubMed:11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Downregulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed:14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity).

    Gene: CEBPA

    Molekulargewicht
    45kDa
    Gen-ID
    1050
    UniProt
    P49715
    Pathways
    Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Sie sind hier:
Kundenservice